Skip to main content

Table 3 Site of first progression (n = 14)

From: Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma

Location of first progression

Patients

Number

Percentage

Documented progression on CT

 Liver

2

20

 Lung

2

13

 Lymph node

1

7

 Peritoneum

1

7

 Pleural effusion

1

7

No progression documented

 Clinical deterioration

3

20

 Death without progression

2

13

 Withdrawn due to adverse events

2

13